278 related articles for article (PubMed ID: 19250190)
21. The roles of aldo-keto reductases in steroid hormone action.
Bauman DR; Steckelbroeck S; Penning TM
Drug News Perspect; 2004 Nov; 17(9):563-78. PubMed ID: 15645014
[TBL] [Abstract][Full Text] [Related]
22. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
[TBL] [Abstract][Full Text] [Related]
23. Pathways and genes involved in steroid hormone metabolism in male pigs: a review and update.
Robic A; Faraut T; Prunier A
J Steroid Biochem Mol Biol; 2014 Mar; 140():44-55. PubMed ID: 24239507
[TBL] [Abstract][Full Text] [Related]
24. AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells.
Wang S; Yang Q; Fung KM; Lin HK
Mol Cell Endocrinol; 2008 Jul; 289(1-2):60-6. PubMed ID: 18508192
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer.
Himura R; Kawano S; Nagata Y; Kawai M; Ota A; Kudo Y; Yoshino Y; Fujimoto N; Miyamoto H; Endo S; Ikari A
Chem Biol Interact; 2024 Jan; 388():110840. PubMed ID: 38122923
[TBL] [Abstract][Full Text] [Related]
26. AKR1C3 as a target in castrate resistant prostate cancer.
Adeniji AO; Chen M; Penning TM
J Steroid Biochem Mol Biol; 2013 Sep; 137():136-49. PubMed ID: 23748150
[TBL] [Abstract][Full Text] [Related]
27. New frontiers in androgen biosynthesis and metabolism.
Penning TM
Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):233-9. PubMed ID: 20186052
[TBL] [Abstract][Full Text] [Related]
28. Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer.
Hamid AR; Pfeiffer MJ; Verhaegh GW; Schaafsma E; Brandt A; Sweep FC; Sedelaar JP; Schalken JA
Mol Med; 2013 Jan; 18(1):1449-55. PubMed ID: 23196782
[TBL] [Abstract][Full Text] [Related]
29. Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase.
Fujimori K; Ueno T; Nagata N; Kashiwagi K; Aritake K; Amano F; Urade Y
J Biol Chem; 2010 Mar; 285(12):8880-6. PubMed ID: 20093363
[TBL] [Abstract][Full Text] [Related]
30. PTHrP stimulates prostate cancer cell growth and upregulates aldo-keto reductase 1C3.
Downs TM; Burton DW; Araiza FL; Hastings RH; Deftos LJ
Cancer Lett; 2011 Jul; 306(1):52-9. PubMed ID: 21444150
[TBL] [Abstract][Full Text] [Related]
31. Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships.
Adeniji AO; Twenter BM; Byrns MC; Jin Y; Chen M; Winkler JD; Penning TM
J Med Chem; 2012 Mar; 55(5):2311-23. PubMed ID: 22263837
[TBL] [Abstract][Full Text] [Related]
32. Porcine aldo-keto reductase 1C subfamily members AKR1C1 and AKR1C4: Substrate specificity, inhibitor sensitivity and activators.
Endo S; Morikawa Y; Matsunaga T; Hara A; Nishinaka T
J Steroid Biochem Mol Biol; 2022 Jul; 221():106113. PubMed ID: 35398259
[TBL] [Abstract][Full Text] [Related]
33. Engineering steroid hormone specificity into aldo-keto reductases.
Penning TM; Ma H; Jez JM
Chem Biol Interact; 2001 Jan; 130-132(1-3):659-71. PubMed ID: 11306084
[TBL] [Abstract][Full Text] [Related]
34. Molecular determinants of steroid recognition and catalysis in aldo-keto reductases. Lessons from 3alpha-hydroxysteroid dehydrogenase.
Penning TM
J Steroid Biochem Mol Biol; 1999; 69(1-6):211-25. PubMed ID: 10418995
[TBL] [Abstract][Full Text] [Related]
35. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
Negri-Cesi P; Colciago A; Poletti A; Motta M
Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the major single nucleotide polymorphic variants of aldo-keto reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase).
Detlefsen AJ; Wangtrakuldee P; Penning TM
J Steroid Biochem Mol Biol; 2022 Jul; 221():106121. PubMed ID: 35489629
[TBL] [Abstract][Full Text] [Related]
37. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
38. Role of aldo-keto reductases in development of prostate and breast cancer.
Jin J; Krishack PA; Cao D
Front Biosci; 2006 Sep; 11():2767-73. PubMed ID: 16720349
[TBL] [Abstract][Full Text] [Related]
39. Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor.
Penning TM; Bauman DR; Jin Y; Rizner TL
Mol Cell Endocrinol; 2007 Feb; 265-266():77-82. PubMed ID: 17223255
[TBL] [Abstract][Full Text] [Related]
40. Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers.
Veliça P; Davies NJ; Rocha PP; Schrewe H; Ride JP; Bunce CM
Mol Cancer; 2009 Dec; 8():121. PubMed ID: 20003443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
